WithdrawnNot Applicable

The Effect of tDCS on Schizophrenia With Negative Symptoms

Stopped: Cancelled

South Korea0Started 2019-12-01

Plain-language summary

The investigators conducted a randomized controlled trial to reveal the effect of tDCS on negative symptoms in patients with schizophrenia and its underlying mechanism using the neuroimaging and electrophysiology.

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * DSM-IV Schizophrenia * 1 or more items of Negative symptom score in PANSS \> 5 Exclusion Criteria: * presences of neurological disorder or history * IQ \< 70 * presence of severe personality disorders * presence of substance use disorder (except nicotin) * pregnancy * presence of severe medical condition or disorders

What they're measuring

Positive and Negative Syndrome Scale (PANSS)

Timeframe: approximately 2 weeks (baseline and 2 weeks followups)

Trial details

NCT IDNCT03729791

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-01

View on ClinicalTrials.gov More Schizophrenia trials